Heather K. Beasley was among the researchers who visited Washington, D.C to push for sustained NIH funding during AACR...
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
A new fellowship program is giving 20 early-career researchers a window into oncology drug development and the regulatory review...
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
With coronavirus infections on the rise, we all feel the strain of the pandemic. The stress has deepened for those who are caring for people who are...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
In June 2020, the American Association for Cancer Research (AACR) hosted the second class of Global Scholar-In-Training Awardees (GSITA) during...